Mirae Asset Global ETFs Holdings’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$113K Buy
18,329
+2,190
+14% +$18.2K ﹤0.01% 2612
2025
Q4
$168K Sell
16,139
-44
-0.3% -$442 ﹤0.01% 2429
2025
Q3
$145K Sell
16,183
-4,199
-21% -$36.9K ﹤0.01% 2482
2025
Q2
$265K Sell
20,382
-1,479
-7% -$22.2K ﹤0.01% 2142
2025
Q1
$552K Buy
21,861
+1,232
+6% +$36.6K ﹤0.01% 1821
2024
Q4
$709K Buy
20,629
+1,001
+5% +$45.1K ﹤0.01% 1734
2024
Q3
$970K Buy
19,628
+4,985
+34% +$255K ﹤0.01% 1556
2024
Q2
$881K Buy
+14,643
New +$837K ﹤0.01% 1525

Other funds holding RXST

Mirae Asset Global ETFs Holdings's RXST Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its RxSight (RXST) stake by 14% in Q1 2026, buying an estimated $18.2K and bringing the position to 18,329 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #2612.

Mirae Asset Global ETFs Holdings first reported a position in RXST in Q2 2024 and has held it in 8 quarters since. The position peaked at $970K in Q3 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 18,329 shares of RxSight worth $113K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 2,190 RxSight shares in Q1 2026, an estimated $18.2K.
  • RxSight made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2612 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in RxSight in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's RxSight position peaked at $970K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.